The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review
Bone · 2025-10 · 199 · 117563
DOI: 10.1016/j.bone.2025.117563 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Bone, 2025-10. Verfasst von Meircurius Dwi Condro Surboyo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan; Department of Oral Med…. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Diphosphonates, Imidazoles, Zoledronic Acid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Naito Foundation.
Abstract (Originalsprache)
OBJECTIVE: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a debilitating condition characterized by alveolar bone destruction associated with bisphosphonate medications, such as zoledronate. Zoledronate use is associated with an increased incidence of BRONJ. In rodent models, accurate replication of BRONJ stages depends on the route of zoledronate administration. This systematic review evaluates the reproducibility of BRONJ characteristics in rodent models by analyzing the effects of different zoledronate injection routes on clinical, histopathological, and radiological outcomes. METHODS: A systematic literature search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines using keywords related to BRONJ and zoledronate. The following data were collected from the selected studies: characteristics of mice and rats; zoledronate dose, duration, and route of administration. The BRONJ stage was determined in these studies based on clinical, histopathological, and radiological features of alveolar bone necrosis. RESULTS: Zoledronate treatment notably affected the reproducibility of BRONJ characteristics. Mice and rats exhibited distinct characteristics in producing BRONJ, depending on the route of zoledronate injection. Subcutaneous, intraperitoneal (IP), and intravenous (IV) injections in rats consistently produced exposed alveolar bone, the main criterion for clinical BRONJ. IP and IV zoledronate injection in mice produced a clinical BRONJ model. Neither mice nor rats exhibited differences in BRONJ characteristics according to sex. CONCLUSIONS: Rodent models of BRONJ mimic the staging and characteristics of BRONJ observed in humans. Rat BRONJ models were more consistently reproducible when the zoledronate administration route was tailored to achieve specific research objectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan; Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 601…
- Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan; Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Universitas Airlan…
- Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
- Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan; Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.
- School of Life Dentistry at Niigata, The Nippon Dental University, Niigata 951-8580, Japan.
- Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Naito Foundation
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
Zitieren
APA
Surboyo, M. D. C., El Fadhlallah, P. M., Sato-Yamada, Y., Sirisereephap, K., Fang, M., Maeda, T., Tomihara, K., Tabeta, K., Yoshiba, N., Rosenkranz, A. L., & Maekawa, T. (2025). The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review. Bone, 199, 117563. https://doi.org/10.1016/j.bone.2025.117563
Vancouver
Surboyo MDC, El Fadhlallah PM, Sato-Yamada Y, Sirisereephap K, Fang M, Maeda T, et al. The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review. Bone. 2025;199:117563. doi:10.1016/j.bone.2025.117563
BibTeX
@article{Surboyo2025,
author = {Surboyo, Meircurius Dwi Condro and El Fadhlallah, Prasiddha Mahardhika and Sato-Yamada, Yurie and Sirisereephap, Kridtapat and Fang, Meiwen and Maeda, Takeyasu and Tomihara, Kei and Tabeta, Koichi and Yoshiba, Nagako and Rosenkranz, Andrea L and Maekawa, Tomoki},
title = {The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review},
journal = {Bone},
year = {2025},
volume = {199},
pages = {117563},
doi = {10.1016/j.bone.2025.117563}
}
EUVIMED